Cynthia M. Butitta's Insider Trades & SAST Disclosures
Cynthia M. Butitta's most recent trade in UroGen Pharma Ltd was a trade of 10,000 Stock Option (right ot buy) done . Disclosure was reported to the exchange on Aug. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cynthia M. Butitta.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. | 12 Aug 2020 | 83,876 | 83,876 | - | 4.4 | 369,558 | Common Stock |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 83,876 | 0 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2020 | 83,876 | 83,876 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2020 | 21,520 | 21,520 | - | - | Stock Option (Right to Buy) | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges